메뉴 건너뛰기




Volumn 154, Issue SPEC. ISS. 2, 2003, Pages

French Nationwide Survey of Abstinence-oriented Treatments in Opiate-Addicted patients. Results at twelve months;Observatoire national des Traitements visant à l'Abstinence d'agonistes opiacés chez les patients Dépendants (OTAD). Résultats à 12 mois

Author keywords

Addiction; Opiate antagonists; Primary care

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; ALPHA INTERFERON; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CANNABIS; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; FLUNITRAZEPAM; METHADONE; NALTREXONE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; PSYCHEDELIC AGENT; RIBAVIRIN;

EID: 1142291734     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (1)

References (28)
  • 2
    • 1142290168 scopus 로고
    • Place et moyens du sevrage ambulatoire du toxicomane. Pratiques actuelles, y compris en médecine générale
    • Bailly D, Venisse JL, eds., 25 et 26 mars 1993, Lille. Paris: Masson
    • c Congrès International sur les Addictions, 25 et 26 mars 1993, Lille. Paris: Masson, 1994: 219-27.
    • (1994) c Congrès International sur les Addictions , pp. 219-227
    • Binder, P.1
  • 3
    • 0035194043 scopus 로고    scopus 로고
    • Practice-based buprenorphine maintenance treatment (BMT): How do French healthcare providers manage the opiate-addicted patients?
    • VIGNAU J, DUHAMEL A, CATTEAU J, et al.: Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients? J Subst Abuse Treat, 2001: 21: 135-44.
    • (2001) J Subst Abuse Treat , vol.21 , pp. 135-144
    • Vignau, J.1    Duhamel, A.2    Catteau, J.3
  • 4
    • 0035798754 scopus 로고    scopus 로고
    • Deaths attributable to methadone vs buprenorphine in France
    • AURIACOMBE M, FRANQUES P, TIGNOL J: Deaths attributable to methadone vs buprenorphine in France. JAMA, 2001; 285: 45.
    • (2001) JAMA , vol.285 , pp. 45
    • Auriacombe, M.1    Franques, P.2    Tignol, J.3
  • 5
    • 17644439360 scopus 로고    scopus 로고
    • Diminution du nombre des surdoses mortelles à l'héroï ne en France depuis 1994: À propos du rôle des traitements de substitution
    • LEPÈRE B, GOURARIER L, SANCHEZ M, et al.: Diminution du nombre des surdoses mortelles à l'héroïne en France depuis 1994: à propos du rôle des traitements de substitution [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments]. Aim Med Interne (Paris), 2001; 152 (Supp. 3): 5-12.
    • (2001) Aim Med Interne (Paris) , vol.152 , Issue.SUPPL. 3 , pp. 5-12
    • Lepère, B.1    Gourarier, L.2    Sanchez, M.3
  • 7
    • 0032501365 scopus 로고    scopus 로고
    • National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction - Effective medical treatment of opiate addiction
    • National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction - Effective medical treatment of opiate addiction. JAMA, 1998; 280: 1936-43.
    • (1998) JAMA , vol.280 , pp. 1936-1943
  • 8
    • 0004242801 scopus 로고    scopus 로고
    • Soigner les toxicomanes
    • ed. Paris: Dunod
    • MOREL A, HERVE F, FONTAINE B: Soigner les toxicomanes. In: Thérapie, ed. Paris: Dunod, 1997: 364.
    • (1997) Thérapie , pp. 364
    • Morel, A.1    Herve, F.2    Fontaine, B.3
  • 9
    • 0015827905 scopus 로고
    • Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man
    • MARTIN WR, JASINSKI DR, MANSKY PA: Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. Arch Gen Psychiatry, 1973; 28: 784-91.
    • (1973) Arch Gen Psychiatry , vol.28 , pp. 784-791
    • Martin, W.R.1    Jasinski, D.R.2    Mansky, P.A.3
  • 10
    • 0015621851 scopus 로고
    • Dynamics of drug dependence. Implications of a conditioning theory for research and treatment
    • WIKLER A: Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. Arch Gen Psychiatry, 1973; 28: 611-6.
    • (1973) Arch Gen Psychiatry , vol.28 , pp. 611-616
    • Wikler, A.1
  • 12
    • 0028569672 scopus 로고
    • A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification
    • AMASS L, BICKEL WK, HIGGINS ST, HUGHES JR: A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification. J Addict Dis, 1994; 13: 33-45.
    • (1994) J Addict Dis , vol.13 , pp. 33-45
    • Amass, L.1    Bickel, W.K.2    Higgins, S.T.3    Hughes, J.R.4
  • 13
    • 0031756421 scopus 로고    scopus 로고
    • Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine
    • VIGNAU J: Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine. Eur Addict Res, 1998; 4: 29-31.
    • (1998) Eur Addict Res , vol.4 , pp. 29-31
    • Vignau, J.1
  • 15
    • 84907120220 scopus 로고
    • Narcotic antagonist treatment: Clinical experience with naltrexone
    • LEWIS DC, MAYER J, HERSCH RG, BLACK R: Narcotic antagonist treatment: clinical experience with naltrexone. Int J Addict, 1978; 13: 961-73.
    • (1978) Int J Addict , vol.13 , pp. 961-973
    • Lewis, D.C.1    Mayer, J.2    Hersch, R.G.3    Black, R.4
  • 16
    • 0030760677 scopus 로고    scopus 로고
    • Compliance to naltrexone treatment after ultra-rapid opiate detoxification: An open label naturalistic study
    • RABINOWITZ J, COHEN H, TARRASCH R, KOTLER M: Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study. Drug Alcohol Depend, 1997; 47: 77-86.
    • (1997) Drug Alcohol Depend , vol.47 , pp. 77-86
    • Rabinowitz, J.1    Cohen, H.2    Tarrasch, R.3    Kotler, M.4
  • 18
    • 0023975281 scopus 로고
    • Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence
    • GONZALEZ JP, BROGDEN RN: Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 1988; 35: 192-213.
    • (1988) Drugs , vol.35 , pp. 192-213
    • Gonzalez, J.P.1    Brogden, R.N.2
  • 19
    • 0032772497 scopus 로고    scopus 로고
    • Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans
    • SCHUH KJ, WALSH SL, STITZER ML: Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology (Berl), 1999; 145: 162-74.
    • (1999) Psychopharmacology (Berl) , vol.145 , pp. 162-174
    • Schuh, K.J.1    Walsh, S.L.2    Stitzer, M.L.3
  • 23
    • 0024525093 scopus 로고
    • A multicentre study to introduce naltrexone for opiate dependence in Spain
    • GARCIA-ALONSO F, GUTIERREZ M, SAN L, et al.: A multicentre study to introduce naltrexone for opiate dependence in Spain. Drug Alcohol Depend, 1989; 23: 117-21.
    • (1989) Drug Alcohol Depend , vol.23 , pp. 117-121
    • Garcia-Alonso, F.1    Gutierrez, M.2    San, L.3
  • 24
    • 0025316006 scopus 로고
    • Naltrexone for heroin addiction: Encouraging results from Italy
    • SCHIFANO F, MARRA R: Naltrexone for heroin addiction: encouraging results from Italy. Int J Clin Pharmacol Ther Toxicol, 1990; 28: 144-6.
    • (1990) Int J Clin Pharmacol Ther Toxicol , vol.28 , pp. 144-146
    • Schifano, F.1    Marra, R.2
  • 25
    • 0027948301 scopus 로고
    • Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal
    • PATRICIO LD, MIGUEL N: [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal]. Ann Med Interne (Paris), 1994; 145 (Suppl 3): 28-30.
    • (1994) Ann Med Interne (Paris) , vol.145 , Issue.SUPPL. 3 , pp. 28-30
    • Patricio, L.D.1    Miguel, N.2
  • 26
    • 0025949561 scopus 로고
    • Opioid addiction treatment modalities and some guidelines to their optimal use
    • RAWSON RA, LING W: Opioid addiction treatment modalities and some guidelines to their optimal use. J Psychoactive Drugs, 1991; 23: 151-63.
    • (1991) J Psychoactive Drugs , vol.23 , pp. 151-163
    • Rawson, R.A.1    Ling, W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.